P. aeruginosa in the paranasal sinuses and transplanted lungs have similar adaptive mutations as isolates from chronically infected CF lungs

Journal of Cystic Fibrosis

Volumn 12, Issue 6, 2013, Pages 729-736

  Ciofu, Oana ^a   Johansen, Helle Krogh ^b   Aanaes, Kasper ^b   Wassermann, Tina ^a   Alhede, Morten ^a,b   von Buchwald, Christian ^b   Høiby, Niels ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; BACTERIUM ISOLATE; CASE REPORT; CHRONIC PATIENT; CONTROLLED STUDY; CYSTIC FIBROSIS; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; LUNG INFECTION; LUNG TRANSPLANTATION; MALE; PARANASAL SINUS; PHENOTYPE; PSEUDOMONAS AERUGINOSA;

ADAPTIVE IMMUNITY; CHRONIC DISEASE; CYSTIC FIBROSIS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LUNG; LUNG TRANSPLANTATION; PARANASAL SINUSES; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84888023135     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2013.02.004     Document Type: Article

References (47)

1. Høiby N., Johansen H.K., Moser C., Ciofu O. Clinical relevance of Pseudomonas aeruginosa: a master of adaptation and survival strategies. Pseudomonas. Model organism, pathogen, cell factory 2008, WILEY-VCH GmbH&Co, Weinheim. B.H.A. Rehm (Ed.).
2. Smith E.E., Buckley D.G., Wu Z., Saenphimmachak C., Hoffman L.R., D'Argenio D.A., et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 2006, 103(22):8487-8492.
3. Govan J.R., Nelson J.W. Microbiology of cystic fibrosis lung infections: themes and issues. J R Soc Med 1993, 86(Suppl. 20):11-18.
4. D'Argenio D.A., Wu M., Hoffman L.R., Kulasekara H.D., Deziel E., Smith E.E., et al. Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol 2007, 64(2):512-533.
5. Mahenthiralingam E., Campbell M.E., Speert D.P. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun Feb 1994, 62(2):596-605.
6. Jain M., Ramirez D., Seshadri R., Cullina J.F., Powers C.A., Schulert G.S., et al. Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis. J Clin Microbiol Nov 2004, 42(11):5229-5237.
7. Hancock R.E., Mutharia L.M., Chan L., Darveau R.P., Speert D.P., Pier G.B. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun Oct 1983, 42(1):170-177.
8. Luzar M.A., Montie T.C. Avirulence and altered physiological properties of cystic fibrosis strains of Pseudomonas aeruginosa. Infect Immun Nov 1985, 50(2):572-576.
9. Lee B., Haagensen J.A., Ciofu O., Andersen J.B., Hoiby N., Molin S. Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J Clin Microbiol 2005, 43(10):5247-5255.
10. Lee B., Schjerling C.K., Kirkby N., Hoffmann N., Borup R., Molin S., et al. Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients. Apmis Apr 2011, 119(4-5):263-274.
11. Moser C., van GM Bjarnsholt T., Jensen P.O., Lee B., Hougen H.P., et al. Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host-pathogen interactions in cystic fibrosis. Apmis Feb 2009, 117(2):95-107.
12. Ciofu O., Fussing V., Bagge N., Koch C., Hoiby N. Characterization of paired mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients: antibiotic resistance, beta-lactamase activity and RiboPrinting. J Antimicrob Chemother 2001, 48(3):391-396.
13. Yang L., Jelsbak L., Marvig R.L., Damkiaer S., Workman C.T., Rau M.H., et al. Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci U S A May 3 2011, 108(18):7481-7486.
14. Ciofu O., Mandsberg L.F., Bjarnsholt T., Wassermann T., Hoiby N. Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants. Microbiology Apr 2010, 156(Pt 4):1108-1119.
15. Mainz J.G., Naehrlich L., Schien M., Kading M., Schiller I., Mayr S., et al. Concordant genotype of upper and lower airways P. aeruginosa and S. aureus isolates in cystic fibrosis. Thorax Jun 2009, 64(6):535-540.
16. Hansen S.K., Rau M.H., Johansen H.K., Ciofu O., Jelsbak L., Yang L., et al. Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection. ISME J Jan 2012, 6(1):31-45.
17. Walter S., Gudowius P., Bosshammer J., Romling U., Weissbrodt H., Schurmann W., et al. Epidemiology of chronic Pseudomonas aeruginosa infections in the airways of lung transplant recipients with cystic fibrosis. Thorax Apr 1997, 52(4):318-321.
18. Nunley D.R., Grgurich W., Iacono A.T., Yousem S., Ohori N.P., Keenan R.J., et al. Allograft colonization and infections with pseudomonas in cystic fibrosis lung transplant recipients. Chest May 1998, 113(5):1235-1243.
19. Mathee K., Ciofu O., Sternberg C., Lindum P.W., Campbell J.I., Jensen P., et al. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 1999, 145(Pt 6):1349-1357.
20. Ciofu O., Riis B., Pressler T., Poulsen H.E., Hoiby N. Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob Agents Chemother 2005, 49(6):2276-2282.
21. Mandsberg L.F., Ciofu O., Kirkby N., Christiansen L.E., Poulsen H.E., Hoiby N. Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system. Antimicrob Agents Chemother Jun 2009, 53(6):2483-2491.
22. Aanaes K., Johansen H.K., Poulsen S.S., Pressler T., Buchwald C., Hoiby N. Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization. J Cyst Fibros Jan 2013, 12(1):81-87.
23. Johansen H.K., Aanaes K., Pressler T., Nielsen K.G., Fisker J., Skov M., et al. Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response. J Cyst Fibros Dec 2012, 11(6):525-531.
24. Rau M.H., Hansen S.K., Johansen H.K., Thomsen L.E., Workman C.T., Nielsen K.F., et al. Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts. Environ Microbiol Jun 2010, 12(6):1643-1658.
25. Hansen C.R., Pressler T., Hoiby N. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15years experience. J Cyst Fibros Nov 2008, 7(6):523-530.
26. Pressler T., Karpati F., Granstrom M., Knudsen P.K., Lindblad A., Hjelte L., et al. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods. J Cyst Fibros Jan 2009, 8(1):37-42.
27. Ciofu O., Lee B., Johannesson M., Hermansen N.O., Meyer P., Hoiby N. Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants. Microbiology 2008, 154(Pt 1):103-113.
28. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33(9):2233-2239.
29. Ojeniyi B., Petersen U.S., Hoiby N. Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients. Apmis 1993, 101(2):168-175.
30. Jelsbak L., Johansen H.K., Frost A.L., Thogersen R., Thomsen L.E., Ciofu O., et al. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun 2007, 75(5):2214-2224.
31. Frederiksen B., Koch C., Hoiby N. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). Pediatr Pulmonol 1999, 28(3):159-166.
32. Bjarnsholt T., Jensen P.O., Jakobsen T.H., Phipps R., Nielsen A.K., Rybtke M.T., et al. Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients. PLoS One 2010, 5(4):e10115.
33. Bjarnsholt T., Jensen P.O., Fiandaca M.J., Pedersen J., Hansen C.R., Andersen C.B., et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol Jun 2009, 44(6):547-558.
34. Hoiby N. P. aeruginosa in cystic fibrosis patients resists host defenses, antibiotics. Microbe 2006, 1:571-577.
35. Greenberg S.B. Respiratory consequences of rhinovirus infection. Arch Intern Med Feb 10 2003, 163(3):278-284.
36. Gwaltney J.M., Druce H.M. Efficacy of brompheniramine maleate for the treatment of rhinovirus colds. Clin Infect Dis Nov 1997, 25(5):1188-1194.
37. Gwaltney J.M., Hendley J.O., Phillips C.D., Bass C.R., Mygind N., Winther B. Nose blowing propels nasal fluid into the paranasal sinuses. Clin Infect Dis Feb 2000, 30(2):387-391.
38. Aanaes K., Rickelt L.F., Johansen H.K., von Buchwald C, Pressler T, Hoiby N., et al. Decreased mucosal oxygen tension in the maxillary sinuses in patients with cystic fibrosis. J Cyst Fibros Mar 2011, 10(2):114-120.
39. Worlitzsch D., Tarran R., Ulrich M., Schwab U., Cekici A., Meyer K.C., et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 2002, 109(3):317-325.
40. Giwercman B., Lambert P.A., Rosdahl V.T., Shand G.H., Hoiby N. Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains. J Antimicrob Chemother 1990, 26(2):247-259.
41. Chang W., Small D.A., Toghrol F., Bentley W.E. Microarray analysis of Pseudomonas aeruginosa reveals induction of pyocin genes in response to hydrogen peroxide. BMC Genomics 2005, 6:115.
42. Holzmann D., Speich R., Kaufmann T., Laube I., Russi E.W., Simmen D., et al. Effects of sinus surgery in patients with cystic fibrosis after lung transplantation: a 10-year experience. Transplantation Jan 15 2004, 77(1):134-136.
43. Vital D, Hofer M, Benden C, Holzmann D, Boehler A. Impact of sinus surgery on pseudomonal airway colonization, bronchiolitis obliterans syndrome and survival in cystic fibrosis lung transplant recipients. Respiration in press, Aug 22 http://dx.doi.org/10.1159/000339627.
44. Leung M.K., Rachakonda L., Weill D., Hwang P.H. Effects of sinus surgery on lung transplantation outcomes in cystic fibrosis. Am J Rhinol Mar 2008, 22(2):192-196.
45. Osborn A.J., Leung R., Ratjen F., James A.L. Effect of endoscopic sinus surgery on pulmonary function and microbial pathogens in a pediatric population with cystic fibrosis. Arch Otolaryngol Head Neck Surg Jun 2011, 137(6):542-547.
46. Johansen H.K., Hoiby N. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 1992, 47(2):109-111.
47. Mainz J.G., Hentschel J., Schien C., Cramer N., Pfister W., Beck J.F., et al. Sinonasal persistence of Pseudomonas aeruginosa after lung transplantation. J Cyst Fibros Mar 2012, 11(2):158-161.